Martin C Woodle

Title: Martin C Woodle: Innovator in Liposome Technology

Introduction

Martin C Woodle is a prominent inventor based in Menlo Park, California. He has made significant contributions to the field of liposome technology, holding a total of 13 patents. His work focuses on enhancing drug delivery systems, particularly in the treatment of severe medical conditions.

Latest Patents

One of Woodle's latest patents is titled "Enhanced Circulation Effector Composition and Method." This patent discloses a liposome composition that comprises small, surface-bound effector molecules. The liposomes feature a surface layer of hydrophilic polymer chains, which enhance circulation time in the bloodstream. The effector molecules are attached to the distal ends of these polymer chains. In one embodiment, the effector is polymyxin B, which is utilized for the treatment of septic shock.

Career Highlights

Throughout his career, Martin C Woodle has worked with notable companies such as Liposome Technology, Inc. and Sequus Pharmaceuticals, Inc. His innovative approaches have paved the way for advancements in pharmaceutical formulations and drug delivery systems.

Collaborations

Woodle has collaborated with esteemed colleagues, including Francis J Martin and Samuel Zalipsky. These partnerships have contributed to the development of groundbreaking technologies in the field of liposomes.

Conclusion

Martin C Woodle's contributions to liposome technology and drug delivery systems have had a lasting impact on the medical field. His innovative patents and collaborations continue to influence advancements in treatment methodologies.